US Drug Recall Register

FDA Drug Recalls

11,815 recalls · Class II, newest first

Class II · Moderate risk Terminated

Eemt

Reason CGMP deviations: Lots were recalled due to sub-potency and cGMP violations.

Syntho Pharmaceuticals, Inc. NDC 15310-010-01 D-0378-2019
Class II · Moderate risk Terminated

Eemt Hs

Reason CGMP deviations: Lots were recalled due to sub-potency and cGMP violations.

Syntho Pharmaceuticals, Inc. NDC 15310-020-01 D-0377-2019
Class II · Moderate risk Terminated

Levonorgestrel

Reason CGMP Deviations: these repackaged and redistributed products are being recalled due to a recall notice from the active pharmaceutical ingredient manufacturer for deviations from current Good Manufacturing Practices that were found during a recent FDA inspection.

Spectrum Laboratory Products, Inc. D-0882-2017
Class II · Moderate risk Terminated

Estradiol

Reason CGMP Deviations: these repackaged and redistributed products are being recalled due to a recall notice from the active pharmaceutical ingredient manufacturer for deviations from current Good Manufacturing Practices that were found during a recent FDA inspection.

Spectrum Laboratory Products, Inc. D-0881-2017
Class II · Moderate risk Terminated

Fentanyl Citrate

Reason Labeling: Not Elsewhere Classified- Diluent used to compound product expired prior to the expiration date assigned to the compounded product.

PharMedium Services, Llc NDC 61553-605-52 D-1166-2017
Class II · Moderate risk Terminated

Fentanyl Citrate

Reason Labeling: Not Elsewhere Classified- Diluent used to compound product expired prior to the expiration date assigned to the compounded product.

PharMedium Services, Llc NDC 61553-112-52 D-1165-2017
Class II · Moderate risk Terminated

Estrone

Reason cGMP Deviations: lack of quality assurance at the API manufacturer.

Fagron, Inc NDC 51552-0445-2 D-0792-2017
Class II · Moderate risk Terminated

Estriol

Reason cGMP Deviations: lack of quality assurance at the API manufacturer.

Fagron, Inc NDC 52372-9292-01 D-0791-2017
Class II · Moderate risk Terminated

Phenylephrine 2.5%

Reason Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.

Isomeric Pharmacy Solution, LLC D-0687-2017
Class II · Moderate risk Terminated

Testosterone Cypionate 200 mg/mL

Reason Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.

Isomeric Pharmacy Solution, LLC D-0686-2017
Class II · Moderate risk Terminated

Triamcinolone Diacetate 40 mg/mL

Reason Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.

Isomeric Pharmacy Solution, LLC D-0684-2017
Class II · Moderate risk Terminated

Triamcinolone Acetonide 40 mg/mL

Reason Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.

Isomeric Pharmacy Solution, LLC D-0683-2017
Class II · Moderate risk Terminated

Methylprednisolone Acetate 80 mg/mL

Reason Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.

Isomeric Pharmacy Solution, LLC D-0682-2017
Class II · Moderate risk Terminated

Methylprednisolone Acetate 40 mg/mL

Reason Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.

Isomeric Pharmacy Solution, LLC D-0681-2017
Class II · Moderate risk Terminated

Refresh Tears

Reason Labeling: Not elsewhere classified; product labeling lacks a NDC number, net weight information and does not contain the Drug Facts Panel.

Cell Distributors D-0865-2017
Class II · Moderate risk Terminated

Estradiol

Reason cGMP Deviations; manufacturer initiated recall of API product after deficiencies noted during a recent FDA inspection

Medisca, Inc. NDC 38779-2261-04 D-0666-2017
Class II · Moderate risk Terminated

Estradiol

Reason cGMP Deviations; manufacturer initiated recall of API product after deficiencies noted during a recent FDA inspection

Medisca, Inc. NDC 38779-0869-07 D-0665-2017
Class II · Moderate risk Terminated

Estrone

Reason cGMP Deviations; manufacturer initiated recall of API product after deficiencies noted during a recent FDA inspection

Medisca, Inc. NDC 38779-0891-05 D-0664-2017
Class II · Moderate risk Terminated

Estriol

Reason cGMP Deviations; manufacturer initiated recall of API product after deficiencies noted during a recent FDA inspection

Medisca, Inc. NDC 38779-0732-03 D-0663-2017
Class II · Moderate risk Terminated

Alka-Seltzer Gold

Reason Defective Container: Confirmed customer compliant of small holes or cracks in the foil of blister packs.

Bayer HealthCare Pharmaceuticals, Inc. D-1051-2017
Class II · Moderate risk Terminated

Alka-Seltzer Extra Strength

Reason Defective Container: Confirmed customer compliant of small holes or cracks in the foil of blister packs.

Bayer HealthCare Pharmaceuticals, Inc. D-1050-2017
Class II · Moderate risk Terminated

Alka-Seltzer Original

Reason Defective Container: Confirmed customer compliant of small holes or cracks in the foil of blister packs.

Bayer HealthCare Pharmaceuticals, Inc. D-1044-2017
Class II · Moderate risk Terminated

hCG Body Shaper

Reason Marketed without an Approved NDA/ANDA; FDA analysis has found the product to be tainted with human chorionic gonadotropin, rendering it an unapproved drug

Gary Wood D-0677-2017
Class II · Moderate risk Terminated

Nystatin and Triamcinolone Acetonide Cream

Reason Failed Content Uniformity Specifications; out-of-specification (OOS) results 18-month stability

Taro Pharmaceuticals U.S.A., Inc. NDC 51672-1263-1 D-0676-2017